Factors Influencing Prescription of Anti-Osteoporosis Medication after Hip Fracture among Orthopedic Surgeons

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20250525002

Enrollment

250

Registered

2025-05-25

Start date

2024-11-16

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteoporosis hip fracture osteoporosis anti-osteoporosis medication hip fracture orthopedic prescription prescribing Thailand

Interventions

Thai orthopedic surgeons

Other

Participants

Eligibility

Sex/Gender

All

Age

25 Years to 99 Years

Inclusion criteria

Inclusion criteria: Thai orthopedic surgeons

Exclusion criteria

Exclusion criteria: 1. Surgeons who work outside Thailand 2. Surgeons who do not involve in managing hip fracture patients

Design outcomes

Primary

Measure	Time frame
factors influencing anti-osteoporosis medication prescription at the time of questionnaire response questionnaire	—

Secondary

Measure	Time frame
anti-osteoporosis medication prescribing experiences of Thai orthopedic surgeon at the time of questionnaire response questionnaire	—

Countries

Thailand

Contacts

Public ContactEkasame Vanitcharoenkul

Faculty of Medicine Siriraj Hospital

artvanit@gmail.com0896923204

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026